SHC1 and adrenal cortex carcinoma: As expected, UALCAN data demonstrated that patients with high SHC1 levels had were significantly related to a poor survival rate for ACC (p = 0.0065), CESC (p = 0.027), HNSC (p = 0.00058), KIRC (p < 0.0001), KIRP(p = 0.00018), LGG (p < 0.0001), LUAD (p = 0.00015), READ (p = 0.008), THYM (p = 0.04), MESO (p = 0.00022), and UVM (p < 0.0001) (Figure 2F).